These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19698391)

  • 1. Mechanisms of action of clozapine in the treatment of neuroleptic-resistant and neuroleptic-intolerant schizophrenia.
    Deutch A
    Eur Psychiatry; 1995; 10 Suppl 1():39s-46s. PubMed ID: 19698391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
    Ellenbroek BA; Artz MT; Cools AR
    Eur J Pharmacol; 1991 Apr; 196(1):103-8. PubMed ID: 1678712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
    Deutch AY; Duman RS
    Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the neuroleptic-nonresponsive schizophrenic patient.
    Meltzer HY
    Schizophr Bull; 1992; 18(3):515-42. PubMed ID: 1357741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic clozapine versus chronic haloperidol treatment: differential effects on electrically evoked dopamine efflux in the rat caudate putamen, but not in the nucleus accumbens.
    Feasey-Truger KJ; Alzheimer C; ten Bruggencate G
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):725-30. PubMed ID: 8971732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine response and plasma catecholamines and their metabolites.
    Green AI; Alam MY; Sobieraj JT; Pappalardo KM; Waternaux C; Salzman C; Schatzberg AF; Schildkraut JJ
    Psychiatry Res; 1993 Feb; 46(2):139-49. PubMed ID: 8483973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Vainer JL; Bélanger MC; Turnier L; Beaudry P; Roy JY; Miller R
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1129-41. PubMed ID: 7531355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacoeconomics of clozapine: a review.
    Meltzer HY; Cola PA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study.
    Gemperle AY; Enz A; Pozza MF; Lüthi A; Olpe HR
    Neuroscience; 2003; 117(3):681-95. PubMed ID: 12617972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
    O'Dell SJ; La Hoste GJ; Widmark CB; Shapiro RM; Potkin SG; Marshall JF
    Synapse; 1990; 6(2):146-53. PubMed ID: 2237777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
    Farde L; Nordström AL; Wiesel FA; Pauli S; Halldin C; Sedvall G
    Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
    Klimke A; Klieser E
    Fortschr Neurol Psychiatr; 1995 May; 63(5):173-93. PubMed ID: 7782019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.
    Lee MA; Jayathilake K; Meltzer HY
    Schizophr Res; 1999 May; 37(1):1-11. PubMed ID: 10227103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine.
    Jann MW
    Pharmacotherapy; 1991; 11(3):179-95. PubMed ID: 1677765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
    Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
    Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.